What are the symptoms of myeloproliferative anemia?

Myeloproliferative anemia is a common clinical disease. It is a type of anemia that may develop into leukemia. Therefore, myeloproliferative anemia must be treated as early as possible. The symptoms of anemia are relatively obvious, and there are corresponding treatments. Patients are advised to follow the principle of early detection and early treatment.

1. Generally, the rate of transformation into leukemia increases by more than 50% within one year from the onset of the disease. 90% of patients suffer from anemia. It is often moderate anemia, manifested by pale complexion, dizziness, fatigue, palpitations and shortness of breath after activity, etc. Fever accounts for 50%, of which fever of unknown cause accounts for 10%-15%. The most common sites of infection are the respiratory tract, around the anus and urinary system.

2. Bleeding accounts for 20%, which is common in the respiratory tract, digestive tract, and also intracranial hemorrhage. The early bleeding symptoms are mild, mostly skin and mucous membrane bleeding, gum bleeding or epistaxis. Female patients may have excessive menstruation. The bleeding trend worsens in the late stage, and cerebral hemorrhage becomes one of the main causes of death in patients.

3. The treatment uses the world's most advanced diagnostic and treatment equipment and technology to extract T cells from the patient's body, and then uses the latest international genetic technology to eliminate diseased cells and enhance the resistance of blood cells through four steps: immune diagnosis, immune blocking + clearance, immune repair + activation, and immune reconstruction + protection. At the same time, the most scientific Chinese medicine health and fitness therapy is used for repair and conditioning, ultimately achieving the goal of completely eliminating diseased cells in the body.

4. Use immune cell activation therapy to provide targeted treatment for patients' diseases, changing the previous reliance on hormones, chemotherapy and a small amount of Chinese patent medicine to treat stubborn blood disease defects. It has achieved the ideal effect of high cure rate and low recurrence rate, and has successfully cured tens of thousands of blood disease patients. It is called the gold medal treatment for blood diseases in the 21st century by the World Health Organization.